153 related articles for article (PubMed ID: 28684700)
1. Proteomics Analysis Reveals an Important Role for the PPAR Signaling Pathway in DBDCT-Induced Hepatotoxicity Mechanisms.
Li Y; Liu X; Niu L; Li Q
Molecules; 2017 Jul; 22(7):. PubMed ID: 28684700
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity and proteomic mechanism of Di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) (DBDCT) in vivo.
Tang L; Luo JR; Li YL; Ge R; Li QS
Environ Toxicol Pharmacol; 2017 Apr; 51():38-44. PubMed ID: 28273564
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytochrome P450 3A in rat liver by the Diorganotin (IV) compound di-n-Butyl-di-(4-chlorobenzo-hydroxamato)tin (IV) and Its Probable Mechanism.
Zhang Y; Li Y; Li Q
Molecules; 2012 Sep; 17(9):10994-1009. PubMed ID: 22971584
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in di-n-butyl-di-(4-chlorobenzohydroxamato)tin (IV)-induced hepatotoxicity determined by proteomic profiles.
Tang L; Li YL; Ge R; Li QS
Toxicol Lett; 2012 Sep; 213(2):167-73. PubMed ID: 22732634
[TBL] [Abstract][Full Text] [Related]
5. Organotin compound DBDCT induces CYP3A suppression through NF-κB-mediated repression of PXR activity.
Li Y; Lin N; Ji X; Mai J; Li Q
Metallomics; 2019 May; 11(5):936-948. PubMed ID: 30848264
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced neurotoxicity of Di-n-butyl-di-(4-chlorobenzohydroxamato) Tin (IV) via mitochondria-mediated pathway in PC12 cells.
Ge R; Ma WH; Li YL; Li QS
Toxicol In Vitro; 2013 Feb; 27(1):92-102. PubMed ID: 23041257
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms by which the antitumor compound di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial-mediated signaling pathway in human cancer SGC-7901 cells.
Li Y; Liu J; Li Q
Mol Carcinog; 2010 Jun; 49(6):566-81. PubMed ID: 20336762
[TBL] [Abstract][Full Text] [Related]
8. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson.
Lawrence JW; Li Y; Chen S; DeLuca JG; Berger JP; Umbenhauer DR; Moller DE; Zhou G
J Biol Chem; 2001 Aug; 276(34):31521-7. PubMed ID: 11418601
[TBL] [Abstract][Full Text] [Related]
9. Osthol regulates hepatic PPAR alpha-mediated lipogenic gene expression in alcoholic fatty liver murine.
Sun F; Xie ML; Xue J; Wang HB
Phytomedicine; 2010 Jul; 17(8-9):669-73. PubMed ID: 20042322
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1-Dependent Mitochondria Apoptosis Plays an Essential Role in the Potential Protein Targets of DBDCT-Induced Hepatotoxicity as Revealed by Quantitative Proteomic Analyses.
Song J; Ren Y; Liu L; Wang Y; Shi C; Ji X; Li Y; Li Q
Bioinorg Chem Appl; 2022; 2022():5176300. PubMed ID: 35154294
[TBL] [Abstract][Full Text] [Related]
11. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
Cwinn MA; Jones SP; Kennedy SW
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
[TBL] [Abstract][Full Text] [Related]
12. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
14. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
[TBL] [Abstract][Full Text] [Related]
16. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.
Lee JH; Banerjee A; Ueno Y; Ramaiah SK
Toxicol Sci; 2008 Nov; 106(1):290-9. PubMed ID: 18703563
[TBL] [Abstract][Full Text] [Related]
17. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
18. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
Skrtic S; Carlsson L; Ljungberg A; Lindén D; Michalik L; Wahli W; Oscarsson J
Liver Int; 2005 Feb; 25(1):33-40. PubMed ID: 15698396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
